FDA Approves BYDUREON™ -- The First and Only Once-Weekly Treatment for Type 2 Diabetes - StreetInsider.comBYDUREON is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise ... fda-approved-treatment-type-2-diabetes "With BYDUREON, U.S. physicians and patients can now choose a therapy that offers continuous ...FDA Approves BYDUREON(TM) -- The First and Only Once-Weekly Treatment for Type 2 Diabetes Provides Glycemic Control in a Once-Weekly Dose - CNBCBYDUREON is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise ... fda-approved-treatment-type-2-diabetes "With BYDUREON, U.S. physicians and patients can now choose a therapy that offers continuous blood ...FDA approves Jentadueto™ (linagliptin/metformin hydrochloride) tablets for the treatment of adult patients with type 2 diabetes - Sacramento BeeJENTADUETO can be used along with diet and exercise to help control blood sugar in adults with type 2 diabetes when ... device innovation to manage diabetes. Lilly is also committed to providing solutions beyond therapy – practical tools ...